WO2001051516A3 - Fusionsproteine zur stimulierung von cytotoxischen t-zellen - Google Patents

Fusionsproteine zur stimulierung von cytotoxischen t-zellen Download PDF

Info

Publication number
WO2001051516A3
WO2001051516A3 PCT/DE2001/000134 DE0100134W WO0151516A3 WO 2001051516 A3 WO2001051516 A3 WO 2001051516A3 DE 0100134 W DE0100134 W DE 0100134W WO 0151516 A3 WO0151516 A3 WO 0151516A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
fusion proteins
stimulating cytotoxic
protein
immunizing
Prior art date
Application number
PCT/DE2001/000134
Other languages
English (en)
French (fr)
Other versions
WO2001051516A2 (de
Inventor
Martin Mueller
Nico Michel
Wolfram Osen
Lutz Gissmann
Hanswalter Zentgraf
Original Assignee
Deutsches Krebsforsch
Martin Mueller
Nico Michel
Wolfram Osen
Lutz Gissmann
Hanswalter Zentgraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Martin Mueller, Nico Michel, Wolfram Osen, Lutz Gissmann, Hanswalter Zentgraf filed Critical Deutsches Krebsforsch
Priority to AU2001240424A priority Critical patent/AU2001240424A1/en
Publication of WO2001051516A2 publication Critical patent/WO2001051516A2/de
Publication of WO2001051516A3 publication Critical patent/WO2001051516A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Fusionsprotein, umfassend Zell-Import- und/oder -Export-Signalsenquenzen und ein zur Immunisierung eines Individuums gegen eine Erkankung geeignetes Antigen, und eine hierfür kodierende DNA sowie die Verwendung beider zur Immunisierung eines Individuums gegen Erkankungen, insbesondere Infektions-bedingte, Autoimmun- und Tumor-Erkankungen.
PCT/DE2001/000134 2000-01-13 2001-01-15 Fusionsproteine zur stimulierung von cytotoxischen t-zellen WO2001051516A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001240424A AU2001240424A1 (en) 2000-01-13 2001-01-15 Immunization agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10001230.2 2000-01-13
DE10001230A DE10001230A1 (de) 2000-01-13 2000-01-13 Immunisierungsmittel

Publications (2)

Publication Number Publication Date
WO2001051516A2 WO2001051516A2 (de) 2001-07-19
WO2001051516A3 true WO2001051516A3 (de) 2001-12-27

Family

ID=7627438

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2001/000134 WO2001051516A2 (de) 2000-01-13 2001-01-15 Fusionsproteine zur stimulierung von cytotoxischen t-zellen

Country Status (3)

Country Link
AU (1) AU2001240424A1 (de)
DE (1) DE10001230A1 (de)
WO (1) WO2001051516A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0904880A2 (pt) * 2009-09-04 2011-05-17 Farmacore Biotecnologia Limitada composição farmacêutica contendo um plasmìdeo que expressa a oncoproteìna e7 de hpv-16 fusionada a gd do hsv-1 co-administrado com um plasmìdeo que expressa a il-2 e o seu uso no controle de tumores induzidos por hpv-16

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005265A1 (en) * 1995-07-28 1997-02-13 Marie Curie Cancer Care Transport proteins and their uses
WO1998032866A1 (en) * 1997-01-23 1998-07-30 Marie Curie Cancer Care Fusion proteins for intracellular and intercellular transport and their uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19901008A1 (de) * 1999-01-13 2000-07-20 Deutsches Krebsforsch Peptide zur Inhibierung von HPV E6-Proteinen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005265A1 (en) * 1995-07-28 1997-02-13 Marie Curie Cancer Care Transport proteins and their uses
WO1998032866A1 (en) * 1997-01-23 1998-07-30 Marie Curie Cancer Care Fusion proteins for intracellular and intercellular transport and their uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PABORSKY ET AL.: "Mammalian cell transient expression of tissue factor for the production of antigen", PROTEIN ENGINEERING, vol. 3, no. 6, 1990, pages 547-553, XP001007710 *

Also Published As

Publication number Publication date
AU2001240424A1 (en) 2001-07-24
WO2001051516A2 (de) 2001-07-19
DE10001230A1 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
IL145535A0 (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
WO2001062794A3 (en) 18607, a human calcium channel
WO2001063286A3 (de) Verfahren zur antigen-spezifischen stimulation von t-lymphozyten mit synthetischen peptidbibliotheken
WO2001073027A3 (en) Compositions and methods for therapy and diagnosis of colon cancer
NZ292565A (en) Production of stabilised complement protein-3 convertase
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO2001042277A3 (en) Complementary peptide ligands generated from the human genome
WO2002000718A3 (en) A human calcium channel protein and uses thereof
WO2001051513A3 (en) Ovarian tumor-associated sequences
WO2001051516A3 (de) Fusionsproteine zur stimulierung von cytotoxischen t-zellen
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
WO2002055701A3 (en) Human sugar transporter proteins, potassium channel proteins, phospholipid transporter proteins and methods of use thereof
WO2002016591A3 (en) Human transporter family members and uses thereof
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
WO2004047758A3 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
WO2003068935A3 (en) Methods of therapy and diagnosis
WO2004053061A8 (en) Methods of therapy and diagnosis using targeting of cells that express lax
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
WO2001090365A3 (en) Human protein kinase '13305' and uses therefor
ATE346926T1 (de) Menschliche twik-8 moleküle und ihre verwendung
WO2002057433A3 (de) Hipk-kinasen zur verwendung in der beeinflussung von zellteilung und zellproliferation
WO2004047612A3 (en) Methods of therapy and diagnosis
WO2002012329A3 (en) Compositions and methods for the therapy and diagnosis of head and neck cancer
WO2003048188A3 (en) 15603, a human ion channel family member
WO2002012476A3 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP